October 24 - 27, 2024   Radisson Blu Aqua Hotel, Chicago

Non-CME Educational Activities

All events are scheduled during times that do not conflict with Symposium CME educational programing.

These optional non-CME educational activity and are not approved for CME or continuing education credit. The content of these optional non-CME activities and opinions expressed by presenters are those of the sponsor or presenters.


Translational Research Session

Wednesday, October 23 • 4:00 pm - 6:00 p.m.

sponsored by Lurie Cancer Center Breast Cancer Research Program
PDF Flyer


Clinical Case Reviews: Treatment of a broad range of patients with HR+/HER2-negative metastatic breast cancer

Thursday, October 24 • 11:55 a.m. – 1:00 p.m.

sponsored by Pfizer


Elevate the Possibilities: TRODELVY in Pretreated HR+/HER2- mBC and mTNBC

Friday, October 25 • 7:00 a.m. – 8:15 a.m.

sponsored by Gilead


Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor

Friday, October 25 • 12:10 p.m. – 1:30 p.m.

sponsored by Lilly


TRUQAP + Fulvestrant: A Novel 2L Treatment Option for HR+/HER2− aBC

Saturday, October 26 • 7:30 a.m. – 8:30 a.m.

sponsored by AstraZeneca


Addressing the Needs Across the HR+/HER2- Breast Cancer Landscape: The Role of KISQALI in eBC and mBC

Saturday, October 26 • 12:00 p.m. – 1:15 p.m.

sponsored by Novartis

© 2024 Robert H. Lurie Comprehensive Cancer Center